TY - JOUR
T1 - Coating Bioactive Microcapsules with Tannic Acid Enhances the Phenotype of the Encapsulated Pluripotent Stem Cells
AU - Choi, Daheui
AU - Gwon, Kihak
AU - Hong, Hye Jin
AU - Baskaran, Harihara
AU - Calvo-Lozano, Olalla
AU - Gonzalez-Suarez, Alan M.
AU - Park, Kyungtae
AU - De Hoyos-Vega, Jose M.
AU - Lechuga, Laura M.
AU - Hong, Jinkee
AU - Stybayeva, Gulnaz
AU - Revzin, Alexander
N1 - Funding Information:
This study was supported in part by the grants from the Mayo Clinic Center for Regenerative Medicine, J.W. Kieckhefer Foundation, Al Nahyan Foundation, Regenerative Medicine Minnesota (RMM 101617 TR 004), and NIH (DK107255). Additional support was provided by an NIH Grant EB021911 to H.B. Additional funding was provided by the Mayo Clinic Center for Cell Signaling in Gastroenterology (P30DK084567).
Publisher Copyright:
© 2022 American Chemical Society. All rights reserved.
PY - 2022/6/15
Y1 - 2022/6/15
N2 - Human pluripotent stem cells (hPSCs) may be differentiated into any adult cell type and therefore hold incredible promise for cell therapeutics and disease modeling. There is increasing interest in three-dimensional (3D) hPSC culture because of improved differentiation outcomes and potential for scale up. Our team has recently described bioactive heparin (Hep)-containing core-shell microcapsules that promote rapid aggregation of stem cells into spheroids and may also be loaded with growth factors for the local and sustained delivery to the encapsulated cells. In this study, we explored the possibility of further modulating bioactivity of microcapsules through the use of an ultrathin coating composed of tannic acid (TA). Deposition of the TA film onto model substrates functionalized with Hep and poly(ethylene glycol) was characterized by ellipsometry and atomic force microscopy. Furthermore, the presence of the TA coating was observed to increase the amount of basic fibroblast growth factor (bFGF) incorporation by up to twofold and to extend its release from 5 to 7 days. Most significantly, TA-microcapsules loaded with bFGF induced higher levels of pluripotency expression compared to uncoated microcapsules containing bFGF. Engineered microcapsules described here represent a new stem cell culture approach that enables 3D cultivation and relies on local delivery of inductive cues.
AB - Human pluripotent stem cells (hPSCs) may be differentiated into any adult cell type and therefore hold incredible promise for cell therapeutics and disease modeling. There is increasing interest in three-dimensional (3D) hPSC culture because of improved differentiation outcomes and potential for scale up. Our team has recently described bioactive heparin (Hep)-containing core-shell microcapsules that promote rapid aggregation of stem cells into spheroids and may also be loaded with growth factors for the local and sustained delivery to the encapsulated cells. In this study, we explored the possibility of further modulating bioactivity of microcapsules through the use of an ultrathin coating composed of tannic acid (TA). Deposition of the TA film onto model substrates functionalized with Hep and poly(ethylene glycol) was characterized by ellipsometry and atomic force microscopy. Furthermore, the presence of the TA coating was observed to increase the amount of basic fibroblast growth factor (bFGF) incorporation by up to twofold and to extend its release from 5 to 7 days. Most significantly, TA-microcapsules loaded with bFGF induced higher levels of pluripotency expression compared to uncoated microcapsules containing bFGF. Engineered microcapsules described here represent a new stem cell culture approach that enables 3D cultivation and relies on local delivery of inductive cues.
KW - 3D stem cell cultures
KW - controlled growth factor release
KW - heparin-based microcapsules
KW - microfluidics
KW - nanofilm
KW - tannic acid
UR - http://www.scopus.com/inward/record.url?scp=85132105813&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85132105813&partnerID=8YFLogxK
U2 - 10.1021/acsami.2c06783
DO - 10.1021/acsami.2c06783
M3 - Article
AN - SCOPUS:85132105813
SN - 1944-8244
VL - 14
SP - 27274
EP - 27286
JO - ACS Applied Materials and Interfaces
JF - ACS Applied Materials and Interfaces
IS - 23
ER -